{"disease":{"id":"ligneous-conjunctivitis","name":"ligneous conjunctivitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01554956","title":"Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Kedrion S.p.A.","has_results":true},{"nct_id":"NCT04586062","title":"Sponsor Initiated Expanded Access Protocol, Intermediate-Size Patient Population","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Kedrion S.p.A.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}